Glaucoma News and Research

Latest Glaucoma News and Research

Researchers find ranibizumab drug as effective alternative to laser therapy for treating diabetic retinopathy

In a randomized clinical trial of more than 300 participants, researchers from Johns Hopkins and elsewhere have found that ranibizumab — a drug most commonly used to treat retinal swelling in people with diabetes — is an effective alternative to laser therapy for treating the most severe, potentially blinding form of diabetic retinal disease. Results of the government-sponsored study also show that the drug therapy carries fewer side effects than the currently used laser treatment.

17 Nov 2015

AAO recognizes outstanding eye physicians and surgeons for innovation in patient care

The American Academy of Ophthalmology will pay tribute to outstanding eye physicians and surgeons who have made significant achievements in various areas of the profession. These range from scientific innovation and humanitarian service to education and advocacy. The honorees will be recognized AAO 2015, the Academy's 119th annual meeting in Las Vegas.

13 Nov 2015

Drug used to treat Parkinson's and related diseases may delay or prevent macular degeneration

In a major scientific breakthrough, a drug used to treat Parkinson's and related diseases may be able to delay or prevent macular degeneration, the most common form of blindness among older Americans.

10 Nov 2015

Charles Bonnet syndrome: an interview with Dr. Dominic ffytche

Charles Bonnet syndrome is the name we give to the visual hallucinations associated with eye disease. There are lots of different causes of visual hallucinations. Many different medical problems and medications can cause them, but, when the cause is eye disease, it's referred to as Charles Bonnet Syndrome after Charles Bonnet, who was a natural philosopher in the 18th century.

2 Nov 2015

Saint Louis University ophthalmologist offers tips to manage night vision issues

Owls and cats are at an advantage as the days get darker, but humans may notice their vision takes a hit during their evening commute home as daylight hours shrink.

31 Oct 2015

Q BioMed signs definitive license agreement with Mannin Research

Q BioMed Inc., a biotechnology acceleration company is pleased to announce it has signed a definitive license, with the option to acquire, the platform technology assets of Mannin Research Inc.

30 Oct 2015

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Novartis announced today that the US Food and Drug Administration has approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated to treat asthma or sudden symptoms of COPD.

30 Oct 2015

Latinos with African ancestry at higher risk for glaucoma

Latinos with African ancestry are at a higher risk for high pressure within the eye, a condition that if untreated can damage the optic nerve and impair vision, according to a report in the journal Ophthalmology.

22 Oct 2015

Gait analysis could lead to reduced falls, injuries in people with glaucoma

Washington State University researchers have developed a way to carefully analyze a person's gait with sensors, an innovation that could lead to reduced falls and injuries in people with glaucoma, the second leading cause of blindness in the United States.

22 Oct 2015

Allergan completes acquisition of AqueSys

Allergan plc, a leading global pharmaceutical company, today announced that it has successfully completed the acquisition of AqueSys, Inc. a clinical-stage medical device company focused on developing ocular implants that reduce intraocular pressure (IOP) associated with glaucoma.

19 Oct 2015

QUT's Professor Joanne Wood wins 'Nobel Prize' of international optometry

One of the world's leading experts on visual impairment, ageing and driving, QUT's Professor Joanne Wood, has won the "Nobel Prize" of international optometry for her work.

15 Oct 2015

Envisia's ENV515 (travoprost XR) meets primary efficacy endpoint in phase 2a glaucoma trial

Envisia Therapeutics, a clinical-stage biotechnology company focused on the development of novel extended-release therapies in ophthalmology, today reported results from its first clinical trial of the Company's lead product candidate, ENV515 (travoprost XR).

6 Oct 2015

Matricellular proteins may be key therapeutic targets for common ocular disorders

A special issue of Journal of Ocular Pharmacology and Therapeutics highlights the latest research on matricellular proteins, which play a critical role in inflammation and blood vessel formation in the eye and therefore making them key targets for new therapies to treat common ocular disorders such as glaucoma, dry eye disease, and age-related macular degeneration (AMD).

23 Sep 2015

Quethera receives seed investment funding to develop gene therapy for glaucoma

Quethera, a gene therapy company developing a treatment for glaucoma that could prevent blindness, has received seed investment funding led by Midven’s Rainbow Seed Fund alongside co-investor Cambridge Enterprise, the commercialisation arm of the University of Cambridge, to continue pre-clinical development of their therapy.

18 Sep 2015

UK’s GPs, optometrists confirm link between smoking and loss of vision

Smokey eyes are regarded as sexy, sultry and stunning. But nothing could be further from the truth, according to new research unveiled this National Eye Health Week.

18 Sep 2015

Scientists elucidate genetic interaction that may prove key to development, progression of glaucoma

Scientists at the University of California, San Diego School of Medicine have elucidated a genetic interaction that may prove key to the development and progression of glaucoma, a blinding neurodegenerative disease that affects tens of millions of people worldwide and is a leading cause of irreversible blindness.

11 Sep 2015

IRIDEX launches novel intra-ocular pressure monitoring device

IRIDEX Corporation today announced that it has added a novel intra-ocular pressure (IOP) monitoring device called a tonometer to its suite of commercial products for the global glaucoma market. The new device comes to IRIDEX through a distribution agreement with Icare Finland Plc, a subsidiary of the Revenio Group Corporation, the creator of the tonometer.

8 Sep 2015

Allergan enters into agreement to acquire Aquesys and its XEN45 program

Allergan plc, a leading global pharmaceutical company, and AqueSys, Inc. a private clinical stage medical device company focused on developing ocular implants that reduce intraocular pressure (IOP) associated with glaucoma, today announced that they have entered into an agreement under which Allergan will acquire AqueSys in an all-cash transaction.

4 Sep 2015

BioLight Life Sciences Investments reports operational and financial results for Q2 2015

BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today reported operational and financial results for the second quarter ended June 30, 2015.

1 Sep 2015

Researchers discover that vitamin D may play significant role in preventing AMD among women

Vitamin D has been studied extensively in relation to bone health as well as cancer. Now, a team led by a researcher at the University at Buffalo has discovered that vitamin D may play a significant role in eye health, specifically in the possible prevention of age-related macular degeneration, or AMD, among women who are more genetically prone to developing the sight-damaging disease.

1 Sep 2015

Glaucoma News and Research

Latest Glaucoma News and Research

Researchers find ranibizumab drug as effective alternative to laser therapy for treating diabetic retinopathy

AAO recognizes outstanding eye physicians and surgeons for innovation in patient care

Drug used to treat Parkinson's and related diseases may delay or prevent macular degeneration

Charles Bonnet syndrome: an interview with Dr. Dominic ffytche

Saint Louis University ophthalmologist offers tips to manage night vision issues

Q BioMed signs definitive license agreement with Mannin Research

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Latinos with African ancestry at higher risk for glaucoma

Gait analysis could lead to reduced falls, injuries in people with glaucoma

Allergan completes acquisition of AqueSys

QUT's Professor Joanne Wood wins 'Nobel Prize' of international optometry

Envisia's ENV515 (travoprost XR) meets primary efficacy endpoint in phase 2a glaucoma trial

Matricellular proteins may be key therapeutic targets for common ocular disorders

Quethera receives seed investment funding to develop gene therapy for glaucoma

UK’s GPs, optometrists confirm link between smoking and loss of vision

Scientists elucidate genetic interaction that may prove key to development, progression of glaucoma

IRIDEX launches novel intra-ocular pressure monitoring device

Allergan enters into agreement to acquire Aquesys and its XEN45 program

BioLight Life Sciences Investments reports operational and financial results for Q2 2015

Researchers discover that vitamin D may play significant role in preventing AMD among women

Forensics and toxicology - Industry Focus eBook eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Glaucoma News and Research

Latest Glaucoma News and Research

Forensics and toxicology - Industry Focus eBook eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in